Jian Tang
唐建
Jian Tang is a computer scientist and founder of BioGeometry, a generative-AI protein-design startup. He holds a faculty position at Mila, the Quebec AI Institute affiliated with Université de Montréal, where he is an associate professor with tenure . His research background is in geometric deep learning and deep generative models applied to graph-structured data, placing him among the earliest researchers to apply deep learning to molecular and protein structures . He launched BioGeometry in 2021 (some Gaorong materials cite 2022) to build what he describes as a "ChatGPT for life sciences" — generative models that create novel proteins and molecules for drug discovery and broader bio-manufacturing . The company counts Turing Award winner Yoshua Bengio as its chief scientific adviser and has raised angel and pre-A funding from Gaorong Ventures .
AI-generated — may contain errors, please verify.
Coverage
Rongbao | Generative AI Powers Industries, Snack Chains Hit 10,000 Stores, Chip Tape-Out Success, Healthcare Goes Global
Innovation lights the path to growth.
高榕创投·BioGeometry Completes Pre-A Round, Applying Generative AI to Bio-Manufacturing
Continuously optimizing a generative AI-powered protein design platform.
高榕创投·The Golden Age of Large Models and Generative AI: Every Application Will Be Refreshed and Rewritten | Ronghui Visits Microsoft
Generative AI is driving industry-wide transformation.
高榕创投·BioGeometry's Jian Tang: How to Build a "ChatGPT" for Life Sciences | Gaorong Ventures
Generative AI is powering drug discovery.
高榕创投·Energy storage batteries, chips, and other frontier sectors land funding; smart manufacturing leads the charge overseas | Rongbao · September
September milestone.
高榕创投·BioGeometry Closes Angel Round, Next-Generation AI to Power Macromolecular Drug R&D
Released TorchProtein, the first open-source machine learning platform for macromolecular drug discovery.
高榕创投·





